Provided by Tiger Fintech (Singapore) Pte. Ltd.

CorMedix Inc.

11.62
+0.03000.26%
Post-market: 11.50-0.1200-1.03%16:49 EDT
Volume:1.08M
Turnover:12.40M
Market Cap:864.87M
PE:41.86
High:11.73
Open:11.63
Low:11.34
Close:11.59
Loading ...

CorMedix Inc. Announces $85 Million Public Offering of Common Stock

Reuters
·
01 Jul

HC Wainwright Initiates Coverage on CorMedix With Buy Rating, $20 Price Target

MT Newswires Live
·
30 Jun

CorMedix Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
30 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, TC Energy, Cancer test makers

Reuters
·
28 Jun

CorMedix Inc - Expects $85 Mln Gross Proceeds From Offering

THOMSON REUTERS
·
27 Jun

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
27 Jun

CorMedix Inc - to Offer and Sell $85 Mln in Common Stock

THOMSON REUTERS
·
27 Jun

Press Release: CorMedix Inc. Announces Proposed Public Offering of Common Stock

Dow Jones
·
27 Jun

CorMedix Inc. Conducted Its Annual Stockholders Meeting

Reuters
·
25 Jun

Needham Raises CorMedix's Price Target to $20 from $15, Keeps Buy Rating

MT Newswires Live
·
24 Jun

CorMedix Is Maintained at Buy by D. Boral Capital

Dow Jones
·
23 Jun

CorMedix Expands DefenCath Rollout; Raises Q2 Sales Guidance

MT Newswires Live
·
23 Jun

BRIEF-CorMedix inc. Announces Customer Implementation

Reuters
·
23 Jun

CorMedix Inc - Expects Modest Revenue Contribution in June

THOMSON REUTERS
·
23 Jun

CorMedix Inc - Increases Q2 Net Sales Guidance to $35Mm-$40Mm

THOMSON REUTERS
·
23 Jun

CorMedix Inc - Ldo Customer Begins Implementation of Defencath

THOMSON REUTERS
·
23 Jun

CorMedix Price Target Raised to $17.00/Share From $13.00 by RBC Capital

Dow Jones
·
20 Jun

Cormedix (CRMD) Receives a Rating Update from a Top Analyst

TIPRANKS
·
20 Jun

RBC Adjusts Price Target on CorMedix to $17 From $13, Maintains Outperform, Speculative Risk Rating

MT Newswires Live
·
20 Jun

Cormedix (CRMD) Receives a Buy from RBC Capital

TIPRANKS
·
08 May